ZTI BIOSCIENCES

ZTI BIOSCIENCES is a radiopharmaceutical developer for cancer therapy based on nano-material technology. ZTI, applying its Nano-materials tech to biotech, created a Fully-integrative platform that can integrate all components of a nuclear medicine to the TERACARRIER. ZTI tackles the fundamental weakness of radiopharmaceuticals by preventing the breakoffs of payload isotopes when injected into the body. ZTIs Tech, fundamentally prevents the escape of radioactive payloads with an unbreakable iron-grid. Furthermore, the TERACARRIER is an all-integrative platform that can utilize any Ligand or Radioisotope. It can significantly enhance the performance of the targeting ligands by increasing payload efficacy while removing side-effects coming...

Radiopharmaceuticals,radioisotopes,radioligandtherapy,and nuclearmedicine

Zti biosciences operates in the Biotechnology research industry.

Zti biosciences's revenue is 11m - 100m

Zti biosciences has 11 - 50 employees.